FinZonalExplore Data →
← CompaniesCOMPANY FINANCIAL PROFILE

Sanofi

SNY · CIK 0001121404 · Pharmaceutical Preparations

Last SEC sync: Nov 8, 2026 03:38 UTC

About Sanofi

Several fundamental trends continue to point to a positive outlook for the pharmaceutical industry.

Business information sourced from SEC annual filing filed Feb 17, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.

Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.

Financial highlights

Latest qualifying annual SEC observations · USD
Revenue—Not available
Net Income—Not available
Operating Income—Not available
Total Assets—Not available
Total Liabilities—Not available
Cash and Cash Equivalents—Not available
Operating Cash Flow—Not available
Revenue growth · latest comparable annual periods—
Net profit margin · matching fiscal period—

Historical financial performance

USD billions · Annual SEC observations · Choose a metric

Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.

Annual financial history

USD · Exact fiscal period ends
Period endedRevenueNet incomeOperating incomeAssetsLiabilitiesCashOperating cash flowNet margin
No qualifying annual financial data available.

A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.

Company information

Registered name
Sanofi
Ticker symbol
SNY
CIK
0001121404
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC SIC code
2834
Fiscal year end (MMDD)
1231
Last SEC synchronization
Nov 8, 2026 03:38 UTC
Headquarters / business address
46 AVENUE DE LA GRANDE ARMEE
PARIS, I0 75017
Mailing address
46 AVENUE DE LA GRANDE ARMEE
PARIS, I0 75017
Business phone
33153774400

Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Last company information check: Nov 8, 2026 03:40 UTC. Official website, business descriptions and executive details require separate verification.

Latest SEC filings

Browse filings →
FormFiledReport periodOfficial source
13F-HRNov. 5, 2026Sept. 30, 2026View SEC filing ↗
6-KOct. 30, 2026Sept. 30, 2026View SEC filing ↗
6-KOct. 26, 2026Oct. 26, 2026View SEC filing ↗
SCHEDULE 13G/AOct. 26, 2026View SEC filing ↗
6-KOct. 1, 2026Oct. 1, 2026View SEC filing ↗
6-KSept. 17, 2026Sept. 17, 2026View SEC filing ↗
N-PXAug. 25, 2026June 30, 2026View SEC filing ↗
3Aug. 12, 2026Aug. 6, 2026View SEC filing ↗
4Aug. 12, 2026Aug. 10, 2026View SEC filing ↗
4Aug. 7, 2026Aug. 6, 2026View SEC filing ↗
6-KAug. 6, 2026Aug. 6, 2026View SEC filing ↗
3Aug. 4, 2026Aug. 4, 2026View SEC filing ↗
6-KJuly 30, 2026June 30, 2026View SEC filing ↗
6-KJuly 30, 2026June 30, 2026View SEC filing ↗
13F-HRJuly 28, 2026June 30, 2026View SEC filing ↗
6-KJuly 27, 2026July 27, 2026View SEC filing ↗
SCHEDULE 13G/AJuly 22, 2026View SEC filing ↗
6-KJuly 17, 2026July 17, 2026View SEC filing ↗
6-KJuly 7, 2026July 7, 2026View SEC filing ↗
NT 11-KJune 30, 2026Dec. 31, 2025View SEC filing ↗

Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.